Category
-
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 6, 2021 -
GlobeNewswire
Flywire adds Gary Cunningham as Chief People Officer
May 5, 2021 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma
May 4, 2021 -
PR Newswire
Centivo launches new health plan for self-funded employers in Iowa utilizing Incirca Health Network, powered by MercyOne
May 4, 2021 -
GlobeNewswire
Affinia Therapeutics Closes $110 Million Series B Financing
May 3, 2021 -
GlobeNewswire
Flywire Files Registration Statement with SEC for Proposed Initial Public Offering
May 3, 2021 -
GlobeNewswire
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 1, 2021 -
PR Newswire
Carrot Fertility and Legacy Partner to Expand Access to Male Fertility Care
April 28, 2021 -
GeekWire
Freight forwarding software startup Logixboard lands $13M
April 28, 2021 -
PR Newswire
Announcing 1upHealth’s $25 million Series B led by F-Prime
April 28, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
April 28, 2021 -
GlobeNewswire
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
April 27, 2021 -
Business Today
Dental software start-up CareStack raises $22.5 million to fund expansion
April 27, 2021 -
GlobeNewswire
Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy Program
April 22, 2021 -
GlobeNewswire
Bamboo Selects Snapsheet’s Claims Management Software Platform to Power and Streamline Claims Processes
April 21, 2021 -
PR Newswire
Papaya Announces Tools for Best-in-Class Employee Experience
April 21, 2021 -
Sifted
Proximie raises $38m for augmented reality surgery
April 21, 2021 -
GlobeNewswire
Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing
April 20, 2021 -
PR Newswire
Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China
April 19, 2021 -
Forbes
This Startup Raised $25 Million To Liberate Your Healthcare Data In The Cloud
April 14, 2021 -
PR Newswire
Former Blackboard VP of Engineering to Join Protenus
April 13, 2021 -
PR Newswire
Benchling Appoints Krista Anderson-Copperman to Its Board of Directors
April 13, 2021 -
GlobeNewswire
Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 13, 2021 -
Business Wire
Xilio Therapeutics Strengthens Management Team with R&D Leadership Appointments
April 12, 2021 -
PR Newswire
onehome Partners with Devoted Health to Bring Post-Acute Home-Based Care to Medicare Advantage Members in Arizona, Ohio and San Antonio, TX
April 12, 2021 -
Business Wire
Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors
April 12, 2021 -
PR Newswire
Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021
April 12, 2021 -
PR Newswire
onehome Partners with Devoted Health to Bring Post-Acute Home-Based Care to Medicare Advantage Members in Arizona, Ohio and San Antonio, TX
April 12, 2021 -
GlobeNewswire
RightHand Robotics Introduces Next-Generation RightPick™ 3 Item-handling Robot System at ProMatDX
April 12, 2021 -
GlobeNewswire
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
April 9, 2021 -
Business Wire
Firefly Health Closes $40M Series B Led by Andreessen Horowitz (a16z)
April 7, 2021 -
Business Wire
n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
April 5, 2021 -
PR Newswire
Benchling Hires Richard Wong as CFO and Zach Powers as CISO
April 2, 2021 -
BioSpace
Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR
March 30, 2021 -
PR Newswire
ONTOZRY® (cenobamate) receives European Commission approval for the treatment of drug-resistant focal-onset seizures in adults
March 30, 2021 -
PR Web
Iora Health and Devoted Health Partner in Phoenix
March 29, 2021 -
Business Wire
Xilio Therapeutics Strengthens Leadership Team with the Addition of Two Executives
March 29, 2021 -
GlobeNewswire
Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital
March 25, 2021 -
Patient Ping
Clearlake Capital and Insight Partners-backed Appriss Health Acquires PatientPing to Deliver Comprehensive Care Coordination Solutions
March 23, 2021 -
Forbes
Virtual Reality Startup Raises $29 Million To Help With Chronic Pain
March 23, 2021 -
PR Newswire
Citrine Medicine Announces Receipt of Clinical Trial Waiver from the National Medical Products Administration (NMPA) in China for Narcolepsy Therapy Wakix® (pitolisant) and Partnership With Chinese Alliance for Rare Diseases (CARD)
March 22, 2021 -
PR Newswire
Tradier Announces The Acquisition of Popular Commission Free Mobile Trading App Rho
March 18, 2021 -
Business Wire
WellAir Announces Appointment of Brad Niemann as Executive Vice President of Healthcare
March 18, 2021 -
YourStory
OZiva raises $12M Series B investment by Eight Road Ventures, F-Prime Capital, and Matrix Partners Read more at: https://yourstory.com/2021/03/funding-alert-oziva-raises-12-million-series-b-investment
March 17, 2021 -
GlobeNewswire
Flywire Launches eStore to Enable Digital Commerce Experiences for Clients
March 17, 2021 -
GlobeNewswire
FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies
March 17, 2021 -
GlobeNewswire
Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program
March 16, 2021 -
GlobeNewswire
Wellframe Announces Peer-Reviewed Research Highlighting the Positive Impact of Digital Care Management
March 15, 2021 -
PR Newswire
TraceLink Moves Corporate Headquarters and Expands Global Footprint to Accommodate Future Growth
March 15, 2021 -
Business Wire
Altasciences Conducts Preclinical Studies in Support of Verve Therapeutics’ Gene Editing Approach for Cardiovascular Disease
March 12, 2021 -
GlobeNewswire
Denali Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to ETV:IDS (DNL310) for the Treatment of Patients with Hunter Syndrome (MPS II)
March 11, 2021 -
TechCrunch
Vendr raises huge $60M Series A as its SaaS-purchasing service scales
March 8, 2021 -
PR Newswire
FARAPULSE’s Pivotal ADVENT Trial underway with First Patients Treated with its Breakthrough Pulsed Field Ablation System to Treat Atrial Fibrillation
March 3, 2021 -
GlobeNewswire
Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
March 3, 2021 -
Business Wire
Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
March 2, 2021 -
PR Newswire
Protenus Earned Designation as a Great Place to Work-Certified™ Company in 2021
March 2, 2021 -
Genomics plc
Genomics PLC Completes Oversubscribed $30M Funding Round
March 1, 2021 -
Endpoints News
Six years separated from a rabies vaccine scandal, China’s YishengBio grabs $130M to go big in infectious diseases, cancer
February 26, 2021 -
PR Newswire
Benchling Launches Pioneering Biology Education Initiative
February 25, 2021 -
PR Newswire
Independence Blue Cross and Quartet Health Collaborate to Address Behavioral Health
February 24, 2021 -
PR Newswire
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI
February 24, 2021 -
Endpoints News
Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021
February 24, 2021 -
PR Newswire
Cone Health and Triad HealthCare Network Expand Partnership with PatientPing to Improve Patient Outcomes and Collaboration Amongst Providers
February 23, 2021 -
GlobeNewswire
Beam Therapeutics Announces Acquisition of Guide Therapeutics
February 23, 2021 -
PR Newswire
Centivo Expands its Health Plan into Connecticut
February 22, 2021 -
PR Newswire
Dr. Feng Ren Appointed as Chief Scientific Officer of Insilico Medicine
February 22, 2021 -
PR Newswire
The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma
February 22, 2021 -
PR Newswire
PatientPing’s National Network of Accountable Care Organizations Earns Over $260 Million in Savings Under the Next Generation ACO Model
February 18, 2021 -
GlobeNewswire
Ultragenyx Announces Approval of Dojolvi™ (UX007/triheptanoin) in Canada for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children
February 17, 2021 -
GlobeNewswire
Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
February 17, 2021 -
MobiHealthNews
Care navigation platform Cohort scores $11M, Sitka lands $14M for specialty care telemedicine and other digital health fundings
February 16, 2021 -
GlobeNewswire
Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II)
February 12, 2021 -
Business Wire
Ensoma Announces Strategic Collaboration with Takeda to Accelerate Next-Generation In Vivo Gene Therapies
February 11, 2021 -
Business Wire
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
February 11, 2021 -
PR Newswire
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
February 10, 2021 -
STAT
Equip, a startup providing virtual therapy for eating disorders, raises $13 million
February 10, 2021 -
GlobeNewswire
Flywire Expands Digital Education Payments Business in Latin America
February 10, 2021 -
GlobeNewswire
Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
February 9, 2021 -
GlobeNewswire
Adagene Inc. Announces Pricing of Initial Public Offering
February 9, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma
February 8, 2021 -
GlobeNewswire
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
February 5, 2021 -
GlobeNewswire
Orchard Therapeutics Announces $150 Million Strategic Financing Strengthened Financial Position Supports Execution into the First Half of 2023
February 5, 2021 -
FierceBiotech
Biotech Sana snags $587.5M IPO to catapult cell therapies into the clinic
February 4, 2021 -
GlobeNewswire
Inmar Intelligence Adds Protenus to Continue Combatting Opioid Epidemic
February 4, 2021 -
Business Wire
Syngenta Crop Protection and Insilico Medicine to Harness Artificial Intelligence to Transform Sustainable Product Innovation
February 3, 2021 -
GlobeNewswire
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
February 2, 2021 -
PR Newswire
VitalCDM® Ranked #1 in KLAS Revenue Cycle, Chargemaster Management Category for Third Year in a Row
February 2, 2021 -
PR Newswire
Whatfix Launches Digital Adoption Solutions for Desktop and Mobile Applications to Accelerate Enterprise-wide Adoption of Multi-Platform Applications
February 2, 2021 -
PR Newswire
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer
February 2, 2021 -
GlobeNewswire
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
February 1, 2021